Log In
Print
BCIQ
Print
Print this Print this
 

Lung cancer vaccine (MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI)) (GSK1572932A)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCancer vaccine against MAGE-A3 antigen
Molecular Target Melanoma-associated antigen A3 (MAGEA3)
Mechanism of ActionVaccine
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today